Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Additional Phase 1 Study of NPC-22 for High Dosage in Healthy Adult Males

NCT04503863 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.

NCT NCT04503863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04503863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Additional Phase 1 Study of NPC-22 for High Dosage in Healthy Adult Males
Lead sponsor
Nobelpharma
Phase
Phase 1
Overall status
Completed
Start date
July 20, 2020
Completion date
December 28, 2021
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety and pharmacokinetics